HeartSciences Inc. (HSCSW) cash flow statement

HSCSWNasdaqFinance ServicesFiscal year ends April 30Also trades as HSCS

Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 3/30

$0.07−0.03 (-30.62%)

Close on Oct 30, 2026Market cap $15.89MP/E –Yield 0.00%

HeartSciences Inc. cash flow statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2026 2026-04-30	FY 2025 2025-04-30	FY 2024 2024-04-30	FY 2023 2023-04-30	FY 2022 2022-04-30
Stock-Based Compensation	1.31	0.25	0.41	0.25	0.07
Deferred Income Taxes	0	0	–	–	–
Change in Accounts Receivable	0.00	0.00	–	0.00	0.00
Change in Inventory	-0.01	-0.02	0.05	0.00	0.08
Change in Accounts Payable	0.00	-0.13	-0.18	0.04	0.36
Operating Cash Flow	-7.43	-7.41	-6.07	-5.77	-3.64
Capital Expenditures	0.00	0.00	-0.06	-0.02	0.00
Investing Cash Flow	-0.04	-0.03	-0.13	-0.02	0.00
Stock Issued	0.17	1.15	–	5.19	–
Financing Cash Flow	8.03	2.73	10	6.53	3.84
Net Change in Cash	0.56	-4.71	4.15	0.74	0.19
Free Cash Flow	-7.43	-7.42	-6.13	-5.79	-3.65

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jul 31, 2026

Profitability, TTM

Gross margin: 60.9%
Operating margin: -209733.1%
Net margin: -227024.2%
Return on equity, FY2026: -4239.9%

Financial strength

Current ratio: 0.14
Debt to equity: 0.00
Debt to assets: 0.0%
Cash to current liabilities: 0.5%

Valuation

P/E ratio: –
Price to sales: 3515.95
Price to book: –
Dividend yield: 0.00%